Drug Enhertu strengthens immune memory against cancer
A Regeneron study found that mice whose tumors disappeared survived weeks after re-injection with the same cancer cells. The immune memory mechanism protected them without further treatment.
- Field
- drugs and trials
- What they did
- Researchers combined an existing cancer drug, Enhertu, with an experimental antibody in mice. This combination completely eliminated tumors, after which the animals remained resistant to re-injection of the same cancer cells for weeks without further treatment.
- Why it matters
- This approach could benefit patients by leveraging the immune system's memory to recognize and attack cancer cells repeatedly, potentially extending survival after remission.
#immunotherapy#cancer#regeneron#tumor#memory



